TFEB and ovarian carcinoma: Also, ATP7B, a lysosomal protein that is induced by TFEB and mediates the cisplatin lysosomal sequestration in resistant ovarian cancer cells [43], was down-regulated in TFEB-silenced cells compared to wild-type cells (Supplemental Fig. S3B), excluding that it was involved in cisplatin resistance upon TFEB silencing.